FOR IMMEDIATE RELEASE.
For more information, contact:
Elizabeth Maynard-Garrett, APR
UTHSC Communications and Marketing
(901) 448-4957, or
Anne W. Manning
UTHSC SCIENTIST RECEIVES NIH GRANT TO PURSUE LIVER CANCER RESEARCH THAT CAN FACILITATE TREATMENT
Memphis, Tennessee (October 28, 2005) – Lakita Cavin, PhD, assistant professor in the University of Tennessee Health Science Center Department of Pharmacology, has been awarded a nearly $600,000 National Institutes of Health (NIH), National Cancer Institute (NCI) grant to study the role of various genes involved in liver cancer.
Already the third deadliest and fifth most common human cancer in the world, the incidence rate and morbidity of liver cancer is steadily increasing due to an escalation in hepatitis B and C viral infections. Dr. Cavin commented, “The aim of our study is to determine the role and function of the genes that are activated during liver tumor progression. Once determined, we can facilitate the development of drugs which can target these genes and treat liver cancer.”
Cavin received her doctorate in chemistry and
This study quantifies the economic impact of the UTHSC on the economy of the state of Tennessee for FY2010.
920 Madison Avenue
Memphis, TN 38163
Phone: (901) 448-5544
Fax: (901) 448-8640